Takeda kicks up GPCR work with Sosei Heptares, dishing out $26M to get GI drug discovery going
Takeda is joining the growing group of big-league players enlisting the GPCR experts at Sosei Heptares for drug design work.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.